FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
GreenSignal Bio Pharma IPO is a book built issue. The issue is entirely an offer for sale of 1.46 crore shares.
GreenSignal Bio Pharma IPO bidding started from November 9, 2016 and ended on November 22, 2016. The allotment for GreenSignal Bio Pharma IPO was finalized on Friday, November 18, 2016. GreenSignal Bio Pharma IPO will list on BSE, NSE with tentative listing date fixed as Tuesday, November 22, 2016.
GreenSignal Bio Pharma IPO price band is set at ₹68 to ₹76 per share. The minimum lot size for an application is 175 Shares. The minimum amount of investment required by retail investors is ₹13,300.
Indian Overseas Bank is the book running lead manager of the GreenSignal Bio Pharma IPO, while Bigshare Services Pvt Ltd is the registrar for the issue.
Refer to GreenSignal Bio Pharma IPO RHP for detailed information.
IPO Date | November 9, 2016 to November 22, 2016 |
Listing Date | [.] |
Face Value | ₹10 per share |
Price Band | ₹68 to ₹76 per share |
Lot Size | 175 Shares |
Total Issue Size | [.] shares (aggregating up to ₹[.] Cr) |
Offer for Sale | 14,579,560 shares of ₹10 (aggregating up to ₹[.] Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
GreenSignal Bio Pharma IPO offers 14,579,560 shares. 10,934,670 (75.00%) to QIB, 2,186,934 (15.00%) to NII, 1,457,956 (10.00%) to RII. 8,331 RIIs will receive minimum 175 shares and (sNII) and (bNII) will receive minimum 2,800 shares. (in case of oversubscription)
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | - | NA |
QIB Shares Offered | 10,934,670 (75.00%) | NA |
NII (HNI) Shares Offered | 2,186,934 (15.00%) | |
Retail Shares Offered | 1,457,956 (10.00%) | 8,331 |
Total Shares Offered | 14,579,560 (100%) |
GreenSignal Bio Pharma IPO opens on November 9, 2016, and closes on November 22, 2016.
IPO Open Date | Wednesday, November 9, 2016 |
IPO Close Date | Tuesday, November 22, 2016 |
Basis of Allotment | Friday, November 18, 2016 |
Initiation of Refunds | Monday, November 21, 2016 |
Credit of Shares to Demat | Monday, November 21, 2016 |
Listing Date | Tuesday, November 22, 2016 |
Cut-off time for UPI mandate confirmation | 5 PM on November 22, 2016 |
Investors can bid for a minimum of 175 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 175 | ₹13,300 |
Retail (Max) | 15 | 2625 | ₹199,500 |
Lot Size Calculator |
Incorporated in 2005, GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source chittorgarh.com, India's No. 1 IPO Investment Portal. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
Both vaccines produced by GreenSignal are generic drugs and company do not require any patents for the same.
GreenSignal has a long term contract with UNICEF to supply the BCG vaccine to UNICEF. GreenSignal is among 4 companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF. Other customers include Indonesia, Nepal and Ministry of Health, India.
GreenSignal Pharma business is organized into domestic and international operations. For FY 2016, GreenSignal's domestic and international operations accounted for 53.79% and 46.20%, respectively, of its net revenues from operations. Visit chittorgarh.com for more detail.
GreenSignal Bio have a manufacturing facility located at Pappankuppam Village, Gummidipoondi, Tiruvallur District, Tamil Nadu.
Particulars | For the year/period ended (in Rs. Lacs) | |||||
---|---|---|---|---|---|---|
As at 30-Jun-16 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | |
Total Assets | 7,099.80 | 6,934.17 | 5,866.98 | 5,694.50 | 5,387.48 | 5,718.08 |
Total Revenue | 1,020.55 | 2,049.25 | 660.29 | 352.80 | 1,169.80 | 1,126.58 |
Profit After Tax (PAT) | 293.09 | 530.95 | (21.33) | (129.71) | (50.01) | (48.11) |
KPI | Values |
---|---|
RoNW | 614% |
The objects of the Offer are to:
1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE;
2. To carry out the sale of up to 14,579,560 Equity Shares by the Selling Shareholders;
3. Enhance visibility and brand image among existing and potential customers; and
4. Provide liquidity to the existing shareholders.
[Dilip Davda] This Company will enjoy first mover advantage in the important generic vaccine sector and will attract fancy going forward. Moderate investment may be considered for long term rewards as the issue size is small and will attract T segment listing for initial period due to which, short term rewards unlikely. Read detail review...
The GreenSignal Bio Pharma IPO is subscribed 1.02 times on November 22, 2016 5:00:00 PM. The public issue subscribed 8.47 times in the retail category, 0.21 times in the QIB category, and 0.13 times in the NII category. Check Day by Day Subscription Details (Live Status)
Category | Subscription (times) |
---|---|
QIB | 0.21 |
NII | 0.13 |
Retail | 8.47 |
Total | 1.02 |
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that according to 26 (2) of SEBI (ICDR) Regulations, if 75% of the net offer to public cannot be allotted to QIBs, the entire application money shall be refunded forthwith. Hence, the IPO of GreenSignal Bio Pharama Limited may be treated as withdrawn.
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been further extended upto 22 Nov,2016. Post issue modification date has been revised to 23 Nov,2016. Price band has been revised to Rs 68/- to Rs 76/-
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been extended upto 17 Nov,2016. Post issue modification date has been revised to 18 Nov,2016.
GreenSignal Bio Pharma Ltd
13/A - 3 Sai Niketan Circular Road,
United India Colony,
Kodambakkam, Chennai 600 024
Phone: +91 44 2472 2244
Email: cs@gsbpl.com
Website: http://www.gsbpl.com
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
GreenSignal Bio Pharma IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at ₹68 to ₹76 per share. The minimum order quantity is 175 Shares.
The IPO opens on November 9, 2016, and closes on November 22, 2016.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The GreenSignal Bio Pharma IPO opens on November 9, 2016 and closes on November 22, 2016.
GreenSignal Bio Pharma IPO lot size is 175 Shares, and the minimum amount required is ₹13,300.
You can apply in GreenSignal Bio Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for GreenSignal Bio Pharma IPO will be done on Friday, November 18, 2016, and the allotted shares will be credited to your demat account by Monday, November 21, 2016. Check the GreenSignal Bio Pharma IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|